Radiopharm Theranostics Ltd share price logo

Radiopharm Theranostics Ltd Share Price

NASDAQ: RADX

Small Cap

$5.15

-0.02

(-0.39%)

as on

Radiopharm Theranostics Ltd Stock Performance

as on November 1, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $5
    $5.31
    downward going graph

    2.91%

    Downside

    3.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.5
    $50.82
    downward going graph

    32.11%

    Downside

    886.80%

    Upside

    downward going graph

Radiopharm Theranostics Ltd share price movements today

Previous Close
$5.17
Open
$5.30
Volume
161.8K
Day's Low - High
$5 - $5.31
52 Week Low - High
$3.5 - $50.82

Radiopharm Theranostics Ltd Historical Returns

1 Month Return
-15.16 %
3 Month Return
-1.68 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Radiopharm Theranostics Ltd Stock Fundamentals & Key Indicators

Check Radiopharm Theranostics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$40.9M

EPS (TTM)

-0.023

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-109.20%

Radiopharm Theranostics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Radiopharm Theranostics Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Radiopharm Theranostics Ltd image
Radiopharm Theranostics Ltd
NA$40.9MNANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$40.4B478.23%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$60.2B253.38%1425.121.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$109.1B101.56%30.3131.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$68.5B16.98%15.6232.13%

Radiopharm Theranostics Ltd Stock’s Investor Sentiment and Interest

Search interest for Radiopharm Theranostics Ltd Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Radiopharm Theranostics Ltd Annual Profit & Loss

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
0
0
3
Gross Profit
0
0
0
0
Operating Income
-19
-34
-36
-38
EBITDA
-17
-31
-44
-38
Interest Expense
9
0
0
0
Depreciation
2
3
3
0
Income Before Tax
-30
-34
-47
-38
Income Tax Expense
0
0
0
0
Net Income
-21
-23
-31
-38
Net Profit Margin
-343550.89%
-11838.59%
-16024.28%
-1055.27%

Radiopharm Theranostics Ltd Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Net Income
-
-
-
-
Operating Cash Flow
-4
-7
-13
-8
Investing Cash Flow
-
-
2
0
Financing Cash Flow
5
22
38
-2
Change in Cash
1
15
27
-9

Radiopharm Theranostics Ltd Annual Cash Flow

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-30
-34
-47
-38
Operating Cash Flow
-9
-23
-22
-36
Investing Cash Flow
-28
-1
0
1
Financing Cash Flow
65
9
30
45
Change in Cash
26
-15
6
10

Insights on Radiopharm Theranostics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, RADX stock has moved down by -15.2%

About Radiopharm Theranostics Ltd

Radiopharm Theranostics Limited is an Australia-based clinical-stage company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. It has a pipeline of differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development from some of the universities and institutes around the world. The clinical program includes one Phase II and two Phase I trials in a variety of solid tumor cancers including lung, pancreas and brain. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, DUNP19 and PTPu. Nano-mAbs is a radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate that utilizes the early steps of fatty acid oxidation.
OrganisationRadiopharm Theranostics Ltd
Headquarters62 Lygon Street, Carlton, VIC, Australia, 3053
CEOMr. Riccardo Canevari
E-voting on sharesClick here to vote

Key Management of Radiopharm Theranostics Ltd

Name

Title

Dr. Dimitris Voliotis M.D.

Chief Medical Officer

Mr. Hitesh Goel

Head of Project Management

Mr. Nathan Jong C.A.

Joint Company Secretary

Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD

Founder & Executive Chairman

Mr. Riccardo Canevari

MD, CEO & Director

Mr. Phillip Hains

CFO, Joint Company Secretary & Executive Director

FAQs

What is Radiopharm Theranostics Ltd share price today?

Radiopharm Theranostics Ltd share price today is $5.15 as on at the close of the market. Radiopharm Theranostics Ltd share today touched a day high of $5.31 and a low of $5.

What is the 52 week high and 52 week low for Radiopharm Theranostics Ltd share?

Radiopharm Theranostics Ltd share touched a 52 week high of $50.82 on and a 52 week low of $3.5 on . Radiopharm Theranostics Ltd stock price today i.e. is closed at $5.15,which is 89.87% down from its 52 week high and 47.30% up from its 52 week low.

What is Radiopharm Theranostics Ltd's market capitalisation today?

Radiopharm Theranostics Ltd market capitalisation is $0.00T as on .

How to invest in Radiopharm Theranostics Ltd Stock (RADX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Radiopharm Theranostics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Radiopharm Theranostics Ltd Shares that will get you 0.2913 shares as per Radiopharm Theranostics Ltd share price of $5.15 per share as on November 1, 2025 at 1:29 am IST.

What is the minimum amount required to buy Radiopharm Theranostics Ltd Stock (RADX) from India?

Indian investors can start investing in Radiopharm Theranostics Ltd (RADX) shares with as little as ₹88.719 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.19 in Radiopharm Theranostics Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Radiopharm Theranostics Ltd share’s latest price of $5.15 as on November 1, 2025 at 1:29 am IST, you will get 1.9417 shares of Radiopharm Theranostics Ltd. Learn more about fractional shares .